Get the Stockscreener App
6.12
2.08%
-0.13
Myomo Inc stock is traded at $6.12, with a volume of 274.54K.
It is down -2.08% in the last 24 hours and down -12.45% over the past month.
Myomo, Inc., a commercial stage medical robotics company, designs, develops, and produces myoelectric braces or orthotics for people suffering with neuromuscular disorders in the United States. It offers MyoPro, a powered upper limb orthosis that supports the arm, as well as restores function to the weakened or paralyzed arms of patients suffering from CVA stroke, brachial plexus injury, traumatic brain injury, spinal cord injury, ALS, or other neuromuscular disease or injury. The company serves orthotics and prosthetics practices or clinics, as well as the veteran administration and other hospitals through orthotics and prosthetics providers, and distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Cambridge, Massachusetts.
See More
Previous Close:
$6.25
Open:
$6.25
24h Volume:
274.54K
Relative Volume:
0.79
Market Cap:
$210.60M
Revenue:
$25.24M
Net Income/Loss:
$-8.38M
P/E Ratio:
-26.61
EPS:
-0.23
Net Cash Flow:
$-9.54M
1W Performance:
+1.49%
1M Performance:
-12.45%
6M Performance:
+68.13%
1Y Performance:
+67.21%
1-Day Range:
$6.03
$6.32
1-Week Range:
$5.85
$6.44
52-Week Range:
$2.5108
$7.1699
Myomo Inc Stock (MYO) Company Profile
Name
Myomo Inc
Sector
Industry
Phone
617-996-9058
Address
One Broadway, 14th Floor, Cambridge, MA
Compare MYO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MYO
Myomo Inc
|
6.105 | 210.60M | 25.24M | -8.38M | -9.54M | -0.23 |
|
ABT
Abbott Laboratories
|
128.84 | 222.39B | 41.95B | 13.40B | 6.49B | 7.65 |
|
BSX
Boston Scientific Corp
|
105.34 | 154.78B | 15.91B | 1.79B | 1.89B | 1.21 |
|
SYK
Stryker Corp
|
391.79 | 150.99B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
89.83 | 116.46B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
71.00 | 41.87B | 6.60B | 4.16B | 490.10M | 6.93 |
Myomo Inc Stock (MYO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-31-24 | Initiated | Craig Hallum | Buy |
| May-20-24 | Initiated | Lake Street | Buy |
| Dec-15-23 | Initiated | H.C. Wainwright | Buy |
| Nov-11-20 | Upgrade | ROTH Capital | Neutral → Buy |
| May-27-20 | Initiated | Dougherty & Company | Buy |
| Oct-02-17 | Initiated | H.C. Wainwright | Buy |
View All
Myomo Inc Stock (MYO) Latest News
MYO (Myomo Inc) may reap gains as insiders became active recently - Knox Daily
Rosalind Advisors, Inc. Increases Stake in Myomo Inc. - GuruFocus.com
Former Medtronic Pelvic Health President Joins Inogen Board: Strategic Move in Respiratory Care Leadership - StockTitan
3 Underrated Robotics Stocks Poised for Major Growth - MarketBeat
Barclays PLC Makes New Investment in Myomo, Inc. (NYSEAMERICAN:MYO) - Defense World
Revisiting Myomo: Valuation Reflects High Growth, But Execution Matters (NYSE:MYO) - Seeking Alpha
Jane Street Group LLC Buys Shares of 16,140 Myomo, Inc. (NYSEAMERICAN:MYO) - Defense World
When (MYO) Moves Investors should Listen - Stock Traders Daily
Geode Capital Management LLC Sells 3,280 Shares of Myomo, Inc. (NYSEAMERICAN:MYO) - Defense World
Barclays PLC Takes Position in Myomo, Inc. (NYSEAMERICAN:MYO) - Defense World
Myomo stock hits 52-week high at $6.88 amid robust growth - Investing.com Australia
Where are the Opportunities in (MYO) - Stock Traders Daily
Myomo Inc (MYO-A) QuotePress Release - The Globe and Mail
Craig Hallum Forecasts Strong Price Appreciation for Myomo (NYSEAMERICAN:MYO) Stock - Defense World
Myomo dips on $15M equity offering - MSN
Myomo stock soars to 52-week high, hits $6.4 amid robust gains - Investing.com Canada
Myomo stock soars to 52-week high, hits $6.4 amid robust gains By Investing.com - Investing.com South Africa
Myomo prices $15M offering to increase headcount amid scale-up - Mass Device
Myomo Announces $15M Public Offering to Fuel Growth and Product Innovation - StockTitan
Myomo, Inc. Announces Proposed Public Offering of Common Stock - Business Wire
Myomo Launches Public Offering to Fuel Growth, Product Development & Market Expansion - StockTitan
Myomo stock hits 52-week high at $5.64 amid robust gains - Investing.com Australia
When the Price of (MYO) Talks, People Listen - Stock Traders Daily
Short Interest in Myomo, Inc. (NYSEAMERICAN:MYO) Decreases By 15.7% - MarketBeat
Myomo (STU:0M61) Forward Dividend Yield % : 0.00% (As of Nov. 25, 2024) - GuruFocus.com
HC Wainwright Issues Pessimistic Estimate for Myomo Earnings - MarketBeat
What is HC Wainwright's Estimate for Myomo FY2028 Earnings? - MarketBeat
Myomo (NYSEAMERICAN:MYO) Stock Price Expected to Rise, Ascendiant Capital Markets Analyst Says - Defense World
Myomo (NYSEAMERICAN:MYO) Price Target Raised to $9.00 - MarketBeat
Nvidia To Rally Around 14%? Here Are 10 Top Analyst Forecasts For TuesdayNVIDIA (NASDAQ:NVDA) - Benzinga
Myomo, Inc. (MYO) Reports Q3 Loss, Tops Revenue Estimates - MSN
Earnings call: Myomo reports record Q3 revenue, eyes future growth - Investing.com India
Earnings call: Myomo reports record Q3 revenue, eyes future growth By Investing.com - Investing.com South Africa
Myomo revenue jumps 81% in Q3 2024 - Medical Buyer
Myomo Inc (MYO) Q3 2024 Earnings Call Highlights: Record Revenue and Strategic Growth Initiatives - GuruFocus.com
Myomo, Inc. Reports Record Third Quarter Growth - TipRanks
Myomo Inc Reports Record Q3 2024 Earnings: Revenue Hits $9.2M, E - GuruFocus.com
Myomo Q3 Revenue Surges 81% to Record $9.2M, Raises Full-Year Guidance | MYO Stock News - StockTitan
Rosalind Advisors Inc. Buys 356,392 Shares of Myomo, Inc. (NYSEAMERICAN:MYO) - MarketBeat
Myomo Reports Record Third Quarter Financial and Operating Results - Business Wire
CMS Decision And O&P Network Build out Make Myomo A Buy (MYO) - Seeking Alpha
Myomo Inc (MYO) Q3 2024: Everything You Need To Know Ahead Of Ea - GuruFocus.com
Myomo Inc (MYO) Q3 2024: Everything You Need To Know Ahead Of Earnings - Yahoo Finance
Myomo Announces First Private Payer Contracts for MyoPro In-network Coverage - Tech Funding News
Extended Session Rally For Myomo (MYO) Stock - Stocks Telegraph
Myomo Inc Stock (MYO) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.75%
0.09%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):